Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 3Urinary Bladder Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Hodgkin Disease 1Extensive Stage Small Cell Lung Cancer 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Cyclophosphamide 241Rituximab 223Etoposide 138Filgrastim 113Vincristine 112Doxorubicin 104Prednisone 90Cytarabine 90Methotrexate 79fludarabine phosphate 77Radiotherapy 76Peripheral Blood Stem Cell Transplantation 71Melphalan 71Busulfan 60Tacrolimus 48Dexamethasone 48Mycophenolic Acid 46Carmustine 46Granulocyte Colony-Stimulating Factor 44fludarabine 43Antilymphocyte Serum 40Ifosfamide 38sargramostim 34Whole-Body Irradiation 34Cyclosporine 33Bortezomib 32Gemcitabine 30Methylprednisolone 27Bendamustine Hydrochloride 27Lenalidomide 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Lymphoma × Podophyllotoxin × Clear all
NCT00274924 2023-06-29

Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Completed
100 enrolled 8 charts
Lymphoid

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT00392990 2019-10-15

Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma

Northwestern University

Phase 2 Completed
25 enrolled 16 charts
Lymphoid

Burkitt Lymphoma, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡